DGAP-News

Celesio AG: Celesio announces results for short fiscal year 2015 - Seite 2

amounted to EUR 3.0m.

Earnings forecast

As previously announced, full-year and prior-year results for the Brazilian
businesses, Panpharma and Oncoprod, are reported as discontinued
operations. With the exception of the decision to place our Brazilian
business for sale, the outlook for our continued operations remains
unchanged from our previous guidance. The following forecasts are based on
the assumption of relatively stable exchange rates and interest rates, when
compared to fiscal 2014.

Overall, the Management Board of Celesio assumes that revenue from
continued operations for fiscal 2016 will be flat compared to the adjusted
fiscal 2014 as solid growth in Germany and the United Kingdom will be
offset by continued weakness in France and the loss of a large hospital
contract in Norway. The adjusted EBIT for continued operations for fiscal
2016 will be considerably below the level of the adjusted fiscal 2014 due
to a non-recurring pension benefit in fiscal 2014 in Norway. The impact of
the expected sale of the Brazilian businesses along with the anticipated
impact of combined McKesson and Celesio procurement synergies are excluded
from the 2016 outlook.

Key figures of the                       1st        short     Change on EUR
Celesio Group                        quarter  fiscal 2015        basis in %
                                        2014
Continuing operations
Revenue                    EUR m     4,990.2      5,269.1               5.6
EBIT                       EUR m        91.0         62.2             -31.6
adjusted1)                 EUR m        98,0         78.6             -19.9
Net profit/loss            EUR m        46.7         33.0             -29.3
adjusted1)                 EUR m        53.7         47.7             -11.2
Free cash flow             EUR m      -132.0        -84.1              36.3
Retail pharmacies3)                    2,180        2,184                 /
Wholesale branches3)                     108          108                 /
Discontinued operations
Net profit/loss            EUR m        -3.6       -255.3             >-100
Continuing and
discontinued operations
Net Financial Debt         EUR m     934.22)      897.03)              -4.0
Net Financial Debt/
EBITDA adj. 1) 4) 5)                  1.712)       1.683)                 /
Employees3)                           38,581       38,404                 /
Net profit/loss            EUR m        43.1       -222.3                 /